Enzular Capsule
Enzalutamide
40 mg
CIPLA LTD
| Pack size | 120's Pack |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price | 74.45 AED |
Indications
Enzular Capsule is used for:
Enzalutamide is indicated for the treatment of patients with metastatic castration-resistant prostate cancer who have previously received docetaxel.
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Enzalutamide :
Mechanism of Action
Enzalutamide is a competitive androgen receptor inhibitor that effects multiple stages of the signalling pathway. It is able to inhibit androgen binding to its receptor, androgen receptor nuclear translocation, and subsequent interaction with DNA. As a result, proliferation of prostate cancer cells decreases which ultimately leads to apoptosis and decreased tumour volume.
Note
Enzular 40 mg Capsule manufactured by CIPLA LTD. Its generic name is Enzalutamide. Enzular is availble in Saudi Arabia.
Farmaco SA drug index information on Enzular Capsule is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.